Cargando…

Chemotherapy for small cell lung cancer: a comprehensive review

Combination chemotherapy is the current strategy of choice for treatment of small cell lung cancer (SCLC). Platinum containing combination regimens are superior to non-platinum regimens in limited stage-SCLC and possibly also in extensive stage-SCLC as first and second-line treatments. The addition...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karim, Syed Mustafa, Zekri, Jamal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	PAGEPress Publications 2012
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4419639/ https://www.ncbi.nlm.nih.gov/pubmed/25992206 http://dx.doi.org/10.4081/oncol.2012.e4

Ejemplares similares

Breaking Cancer Bad News to Patients With Cancer: A Comprehensive Perspective of Patients, Their Relatives, and the Public—Example From a Middle Eastern Country
por: Zekri, Jamal, et al.
Publicado: (2016)

The anti-tumour effects of zoledronic acid
por: Zekri, Jamal, et al.
Publicado: (2014)

The Role of Immunotherapy or Immuno-Chemotherapy in Non-Small Cell Lung Cancer: A Comprehensive Review
por: Mohamed, Shehab, et al.
Publicado: (2023)

Time from last chemotherapy to death and its correlation with the end of life care in a referral hospital
por: Karim, Syed Mustafa, et al.
Publicado: (2015)

Adjuvant Chemotherapy of Non-Small Cell Lung Cancer
por: Pirker, Robert
Publicado: (2012)

Chemotherapy: A partnership with immunotherapy in non‐small cell lung cancer
por: Mendes, Ana Sofia, et al.
Publicado: (2022)

Natural Products Counteracting Cardiotoxicity during Cancer Chemotherapy: The Special Case of Doxorubicin, a Comprehensive Review
por: Koss-Mikołajczyk, Izabela, et al.
Publicado: (2021)

Neoadjuvant Chemotherapy With Capecitabine Plus Cisplatin in Patients With Locally Advanced Nasopharyngeal Cancer: Case Series Study
por: Dada, Reyad, et al.
Publicado: (2016)

A comprehensive review on Brigatinib – A wonder drug for targeted cancer therapy in non-small cell lung cancer
por: Bedi, Silky, et al.
Publicado: (2018)

Novel Cytotoxic Chemotherapies in Small Cell Lung Carcinoma
por: Cortinovis, Diego, et al.
Publicado: (2021)

Systemic Chemotherapy for Progression of Brain Metastases in Extensive-Stage Small Cell Lung Cancer
por: Abdel Karim, Nagla, et al.
Publicado: (2015)

Chemotherapy of non-small cell lung cancer.
por: Williams, C. J.
Publicado: (1989)

Cardiac function in women receiving dual anti-Her2 antibodies (trastuzumab and pertuzumab) combined with chemotherapy for breast cancer
por: Zekri, Jamal, et al.
Publicado: (2023)

Circulating Biomarkers of Response and Toxicity of Immunotherapy in Advanced Non-Small Cell Lung Cancer (NSCLC): A Comprehensive Review
por: Indini, Alice, et al.
Publicado: (2021)

A review on the effects of current chemotherapy drugs and natural agents in treating non–small cell lung cancer
por: Huang, Chih-Yang, et al.
Publicado: (2017)

The prospect of immunotherapy combined with chemotherapy in patients with advanced non-small cell lung cancer: a narrative review
por: Ning, Xiangu, et al.
Publicado: (2021)

Antiangiogenic Agents in Combination with Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer
por: Ulahannan, Susanna V, et al.
Publicado: (2011)

Personalized medicine of non-gene-specific chemotherapies for non-small cell lung cancer
por: Jiang, Wenxiao, et al.
Publicado: (2021)

Comprehensive TCM treatments combined with chemotherapy for advanced non-small cell lung cancer: A randomized, controlled trial
por: Xiao, Zhiwei, et al.
Publicado: (2021)

Adjuvant chemotherapy of non-small-cell lung cancer
por: Douillard, J.Y.
Publicado: (2013)

A comprehensive review of nongenetic prognostic and predictive factors influencing the heterogeneity of outcomes in advanced non-small-cell lung cancer
por: Cuyún Carter, Gebra, et al.
Publicado: (2014)

Multi-Omics Approaches for the Prediction of Clinical Endpoints after Immunotherapy in Non-Small Cell Lung Cancer: A Comprehensive Review
por: Bourbonne, Vincent, et al.
Publicado: (2022)

The Landscape of ALK-Rearranged Non-Small Cell Lung Cancer: A Comprehensive Review of Clinicopathologic, Genomic Characteristics, and Therapeutic Perspectives
por: Cognigni, Valeria, et al.
Publicado: (2022)

Intra-Arterial Infusion Chemotherapy in Advanced Pancreatic Cancer: A Comprehensive Review
por: Laface, Carmelo, et al.
Publicado: (2022)

The impact of a coordinated joint multidisciplinary breast cancer clinic
por: Zekri, Jamal
Publicado: (2017)

Adjuvant chemotherapy for resected non-small-cell lung cancer: future perspectives for clinical research
por: Bonomi, Maria, et al.
Publicado: (2011)

Roles of microRNAs in the resistance to platinum based chemotherapy in the non-small cell lung cancer
por: Zang, Hongjing, et al.
Publicado: (2017)

Selection of Non-small Cell Lung Cancer Patients for Intercalated Chemotherapy and Tyrosine Kinase Inhibitors
por: Zwitter, Matjaz, et al.
Publicado: (2017)

Nephrotoxicity as a Complication of Chemotherapy and Immunotherapy in the Treatment of Colorectal Cancer, Melanoma and Non-Small Cell Lung Cancer
por: Jagieła, Joanna, et al.
Publicado: (2021)

Neoadjuvant sintilimab combined with chemotherapy in resectable locally advanced non-small cell lung cancer: case series and literature review
por: Yin, Cunli, et al.
Publicado: (2023)

Afatinib for the treatment of metastatic non-small cell lung cancer
por: Joshi, Monika, et al.
Publicado: (2015)

Cancer. A Comprehensive Treatise. 5. Chemotherapy
por: Blackledge, G.
Publicado: (1978)

Use of adjuvant chemotherapy in resected non-small cell lung cancer in real-life practice: a systematic review of literature
por: Desage, Anne-Laure, et al.
Publicado: (2021)

Comprehensive review on how platinum- and taxane-based chemotherapy of ovarian cancer affects biology of normal cells
por: Mikuła-Pietrasik, Justyna, et al.
Publicado: (2018)

Comprehensive genomic profiling of combined small cell lung cancer
por: Zhang, Jing, et al.
Publicado: (2021)

Chemotherapy in non-small cell lung cancer: opportunities for advancement
por: Akhtari, Mani, et al.
Publicado: (2016)

Comprehensive T cell repertoire characterization of non-small cell lung cancer
por: Reuben, Alexandre, et al.
Publicado: (2020)

A Comprehensive Review of Contemporary Literature for Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer and Their Toxicity
por: Lee, Chung-Shien, et al.
Publicado: (2020)

Aidi injection as adjunctive treatment to gemcitabine-based chemotherapy for advanced non-small cell lung cancer: a systematic review and meta-analysis
por: Guo, Sitong, et al.
Publicado: (2021)

Duration of Chemotherapy for Small Cell Lung Cancer: A Meta-Analysis
por: Zhou, Hang, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_l5af216emdtqvm853e5fbaa61t